MedTrace Logo

Malglycemia in the Pediatric Hematopoietic Stem Cell Transplant Population

NCT03482154 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 344

Last updated 2019-09-30

No results posted yet for this study

Summary

This is a retrospective chart review of patients who underwent a hematopoietic stem cell transplant (HSCT) between 1994 and 2016 to evaluate incidence of malglycemia and the relationship to specific outcomes.

Conditions

Interventions

PROCEDURE

Hematopoietic Stem Cell Transplant

Allogeneic and autologous stem cell transplants covering both malignant and non-malignant diagnoses.

Sponsors & Collaborators

  • University of Colorado, Denver

    lead OTHER

Principal Investigators

  • Jenna Sopfe, MD · Children's Hospital Colorado

Eligibility

Max Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-06
Primary Completion
2019-06-30
Completion
2019-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03482154 on ClinicalTrials.gov